Technology
Health
Biotechnology

XOMA

$17.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-0.56%) As of 2:48 PM EDT today
-$0.10 (-0.56%) Today

Why Robinhood?

You can buy or sell XOMA and other stocks, options, ETFs, and crypto commission-free!

About XOMA

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. Read More The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Employees
11
Headquarters
Emeryville, California
Founded
1981
Market Cap
154.66M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
45.59K
High Today
$17.75
Low Today
$17.25
Open Price
$17.57
Volume
9.54K
52 Week High
$20.29
52 Week Low
$11.02

Collections

Technology
Health
Biotechnology
Therapy
US
North America

XOMA Earnings

-$0.55
-$0.30
-$0.04
$0.21
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.55 per share
Actual
-$0.47 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.